STAA

STAAR Surgical Company

STAA.US staar.com + Research + Basket
CIK 0000718937
Employees 921
Phone 626 303 7902
Fiscal year end December
IPO Jul 15, 1983
Address 25510 Commercentre Drive, Lake Forest, CA, United States, 92630
24.54
-0.70 (-2.77%)
USD · NASDAQ
52-week range
15.59
35.87
Trading at 44% of the 52-week range
Market Cap
1.27B
P/E Ratio
315.50
Forward P/E
55.87
Book Value
7.29
Div. Yield
N/A
% Institutions
111.59%
% Insiders
0.854%

1 Year

-7.5%

3 Year

-41.3%

10 Year

+192.1%
Description

STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, and sells phakic implantable lenses for the eye and accessory delivery systems to deliver the lenses into the eye. The company offers implantable collamer lens product family (ICLs) comprising EVO ICL, EVO+ ICL, EVO Visian ICL, and EVO Viva ICL for use in refractive surgery for the treatment of visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia. It serves health care providers, including ophthalmic surgeons, vision and surgical centers, hospitals, government facilities, and distributors, as well as ophthalmologists. The company sells its products directly through its sales representatives in Japan, the United States, Germany, Spain, Singapore, Canada, and the United Kingdom, as well as through representatives and independent distributors in China, Korea, India, France, Benelux, Italy, and internationally. STAAR Surgical Company was incorporated in 1982 and is headquartered in Lake Forest, California.

Actions

Add an action for STAA.US, or sign in to see your action list.

People

▼

Directors & Officers

Name Title Year Born
Mr. Warren Foust CEO, President & Director 1976
Ms. Deborah J. Andrews Executive VP & CFO 1957
Dr. Magda Michna Ph.D. Chief Development Officer NA
Dr. Ben Park Ph.D. Chief Technology Officer NA
Ms. Connie Johnson Director of Investor Relations NA
Ms. Kathleen Determann J.D. VP, Deputy General Counsel and Chief Compliance & Privacy Officer NA
Mr. William W. Goodmen Vice President of Global Human Resources 1955
Mr. David Bailey Chief Commercial Officer 1957
Dr. Scott D. Barnes M.D. Chief Medical Officer 1963
Mr. Filip De Keersmaecker Chief Supply Chain & Quality Officer NA

Insider Trading

Open insider trading
Date Insider Name Title Transaction Type Shares Price Value SEC
Mar 13, 2026 Broadwood Partners, L.P. N/A Purchase 316.02K $18.61 $5.88M SEC
Mar 12, 2026 Broadwood Partners, L.P. N/A Purchase 299.43K $18.12 $5.43M SEC
Mar 11, 2026 Broadwood Partners, L.P. N/A Purchase 54.76K $17.52 $959.47K SEC
Jan 09, 2026 Broadwood Partners, L.P. N/A Purchase 27.49K $22.05 $606.04K SEC
Jan 08, 2026 Broadwood Partners, L.P. N/A Purchase 3.24K $21.94 $71.09K SEC
Jan 07, 2026 Broadwood Partners, L.P. N/A Purchase 66.47K $22.00 $1.46M SEC
Jan 06, 2026 Broadwood Partners, L.P. N/A Purchase 336.95K $21.62 $7.28M SEC
Nov 21, 2025 Broadwood Partners, L.P. N/A Purchase 797.49K $27.86 $22.22M SEC
Nov 20, 2025 Broadwood Partners, L.P. N/A Purchase 393.38K $27.14 $10.68M SEC
Nov 19, 2025 Broadwood Partners, L.P. N/A Purchase 309.13K $26.42 $8.17M SEC

Shareholders

▼

Institutional Holders

Holder Name Shares Date Reported % Out Value % Change
BROADWOOD CAPITAL Inc 16.12M Jun 30, 2026 32.16% $24.18 0.00%
BlackRock Inc 6.73M Jun 30, 2026 13.42% $0.00 0.98%
Madison Avenue Partners, LP 4.18M Jun 30, 2026 8.33% $5.16 71.02%
Yunqi Capital Ltd 3.26M Jun 30, 2026 6.50% $74.80 0.00%
Point72 Asset Management, L.P. 2.44M Jun 30, 2026 4.86% $0.08 196.11%
The Goldman Sachs Group Inc 2.15M Jun 30, 2026 4.29% $0.01 101.02%
Vanguard Portfolio Management, LLC 1.98M Jun 30, 2026 3.95% $0.00 -6.78%
State Street Corp 1.77M Jun 30, 2026 3.53% $0.00 -3.47%
Anatole Investment Management Ltd 1.65M Jun 30, 2026 3.29% $8.03 3.12%
Vanguard Capital Management, LLC 1.55M Jun 30, 2026 3.10% $0.00 -8.15%
Morgan Stanley - Brokerage Accounts 1.32M Jun 30, 2026 2.62% $0.00 -12.22%
Geode Capital Management, LLC 1.08M Jun 30, 2026 2.15% $0.00 5.85%
Two Seas Capital LP 1.04M Mar 31, 2026 2.07% $0.27 0.00%
Dimensional Fund Advisors, Inc. 867.14K Jun 30, 2026 1.73% $0.00 5.65%
American Capital Management Inc 846.66K Jun 30, 2026 1.69% $1.09 -3.57%
AI-Squared Management Ltd 542.42K Jun 30, 2026 1.08% $8.30 102.33%
Charles Schwab Investment Management Inc 445.71K Jun 30, 2026 0.89% $0.00 9.09%
Defender Capital, LLC. 429.76K Sep 30, 2026 0.86% $3.04 -0.33%
Northern Trust Corp 423.11K Jun 30, 2026 0.84% $0.00 5.72%
NORGES BANK 365.20K Jun 30, 2026 0.73% $0.00 0.00%

Fund Holdings

Rank Holder Name Shares Held % of Shares Change Date Reported
1 iShares Core S&P Small-Cap ETF 1.79M 3.57% ▲ 0.03% Sep 30, 2026
2 Vanguard MStar Total Stk Mkt Idx Invest 949.46K 1.89% ▲ 0.00% Sep 30, 2026
3 iShares Russell 2000 ETF 790.56K 1.58% ▼ 1.14% Sep 30, 2026
4 Vanguard Small Cap Index 677.52K 1.35% ▼ 1.31% Sep 30, 2026
5 Vanguard MStar Small Cap Growth Indx Inv 377.15K 0.75% ▼ 3.88% Sep 30, 2026
6 Fidelity Small Cap Index 371.06K 0.74% ▲ 0.73% Jul 31, 2026
7 Vanguard Tax-Managed Small Cap Adm 312.37K 0.62% ▲ 0.00% Sep 30, 2026
8 State Street SPDR Port S&P 600 Sm CpETF 276.93K 0.55% ▲ 0.00% Sep 30, 2026
9 iShares Russell 2000 Growth ETF 257.44K 0.51% ▼ 0.13% Sep 30, 2026
10 Fidelity Extended Market Index 245.82K 0.49% ▼ 0.71% Aug 31, 2026

Financial Highlights

▼
Market Cap: $1.27B
EBITDA: $49.76M
P/E Ratio: $315.50
PEG Ratio: $0.76
Book Value: $7.29
Earnings/Share: $0.08
Profit Margin: 1.13%
Operating Margin: 10.89%
ROA (TTM): 5.65%
ROE (TTM): 1.09%
Revenue (TTM): $339.59M
Revenue/Share (TTM): $6.80
Earnings Growth (YOY): -10.50%
Revenue Growth (YOY): 111.00%

Valuation Metrics

Enterprise Value: $1.09B
Trailing P/E: 315.50
Forward P/E: 55.87

Shares Statistics

Shares Outstanding: 50.14M
Shares Float: 26.13M
% Insiders: 0.854%
% Institutions: 111.59%
Shares Short: 3.70M
Shares Short (Prior Month): 3.74M
Short Ratio: 3.76
Short % Float: 15.37%

Stock Price History

▼

1 Year Price History

3 Years Price History

10 Years Price History

Max Price History

Financial Charts

▼
Open balance sheet Open capital intensity Download Financials (Excel)

Revenue, Net Income & Operating Cash Flow (Yearly)

Change % vs Prior Year

Revenue, Net Income & Operating Cash Flow (Quarterly)

Change % vs Prior Quarter

Operating Expenses (Yearly)

Operating Expenses (Quarterly)

Balance Sheet (Yearly)

Balance Sheet (Quarterly)

Assets Breakdown (Yearly)

Assets Breakdown (Quarterly)

Liabilities Breakdown (Yearly)

Liabilities Breakdown (Quarterly)

Income Statement Waterfall

▼
Open full waterfall Open balance sheet
Line Item
Step Type
Value
Revenue
adjust
$239.44M
Cost of Goods Sold
adjust
$-57.02M
Gross Profit
subtotal
$182.42M
SG&A
adjust
$-85.78M
R&D
adjust
$-40.06M
Other Operating Expense
adjust
$-102.53M
Operating Income
subtotal
$-45.95M
Other / Non-Operating Items
adjust
$-34.50M
Net Income
subtotal
$-80.45M

Earnings Per Share (EPS) History

▼

Financial Ratios

▼

📦 Raw API Data (JSON Explorer)

▼

Assistant

×
Hello! I'm your AI assistant. I have access to the financial data on this page. Ask me anything about STAA.US!